X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (57) 57
oncology (50) 50
cancer (45) 45
index medicus (45) 45
female (41) 41
aged (30) 30
male (30) 30
middle aged (29) 29
life sciences (26) 26
adult (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
care and treatment (18) 18
clinical trials (18) 18
treatment outcome (17) 17
radiotherapy (16) 16
aged, 80 and over (15) 15
breast cancer (15) 15
chemotherapy (15) 15
disease-free survival (15) 15
survival (15) 15
hematology, oncology and palliative medicine (14) 14
analysis (13) 13
fluorouracil - administration & dosage (13) 13
radiology, nuclear medicine & medical imaging (13) 13
adenocarcinoma (12) 12
deoxycytidine - analogs & derivatives (12) 12
quality of life (12) 12
research (12) 12
survival analysis (12) 12
clinical-trials (10) 10
metastasis (10) 10
organoplatinum compounds - administration & dosage (10) 10
santé publique et épidémiologie (10) 10
fluorouracil (9) 9
gemcitabine (9) 9
human health and pathology (9) 9
mesh : humans (9) 9
neoplasm staging (9) 9
oxaliplatin (9) 9
prognosis (9) 9
time factors (9) 9
tumors (9) 9
biomarkers (8) 8
cancer therapies (8) 8
docetaxel (8) 8
dose-response relationship, drug (8) 8
france (8) 8
pancreatic cancer (8) 8
usage (8) 8
combined modality therapy (7) 7
deoxycytidine - administration & dosage (7) 7
health-related quality of life (7) 7
leucovorin - administration & dosage (7) 7
mesh : female (7) 7
neoplasms. tumors. oncology. including cancer and carcinogens (7) 7
pancreatic neoplasms - drug therapy (7) 7
patients (7) 7
randomized-trial (7) 7
research article (7) 7
surgery (7) 7
therapy (7) 7
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (6) 6
breast neoplasms - pathology (6) 6
camptothecin - analogs & derivatives (6) 6
capecitabine (6) 6
follow-up studies (6) 6
health aspects (6) 6
leucovorin (6) 6
medical prognosis (6) 6
medicine (6) 6
mesh : male (6) 6
neoadjuvant therapy (6) 6
pancreatic neoplasms - pathology (6) 6
phase-i (6) 6
radiation therapy (6) 6
radiation-therapy (6) 6
radiotherapy dosage (6) 6
surveys and questionnaires (6) 6
survival rate (6) 6
trial (6) 6
adjuvant treatment (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
breast neoplasms - radiotherapy (5) 5
camptothecin - administration & dosage (5) 5
carcinoma (5) 5
chemoradiotherapy (5) 5
colorectal cancer (5) 5
deoxycytidine - therapeutic use (5) 5
disease progression (5) 5
impact (5) 5
longitudinal analysis (5) 5
longitudinal studies (5) 5
mesh : middle aged (5) 5
metastases (5) 5
neoplasms - therapy (5) 5
patient outcomes (5) 5
prospective studies (5) 5
total mesorectal excision (5) 5
toxicity (5) 5
5-fluorouracil (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 305 - 314
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2011, Volume 364, Issue 19, pp. 1817 - 1825
In this study, a four-drug combination chemotherapy regimen was associated with objective responses in more than 30% of patients and increased survival by more... 
PHASE-III TRIAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | SOLID TUMORS | CLINICAL-TRIALS | IRINOTECAN | OXALIPLATIN | 1ST-LINE THERAPY | COMBINATION | CARCINOMA | COOPERATIVE-ONCOLOGY-GROUP | Leucovorin - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Camptothecin - analogs & derivatives | Severity of Illness Index | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Quality of Life | Aged | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Chemotherapy, Combination | Usage | Care and treatment | Gemcitabine | Pancreatic cancer | Leucovorin | Comparative analysis | Drug therapy | Fluorouracil | Clinical trials | Cytotoxicity | Pancreas | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 23 - 29
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 10, pp. 1638 - 1644
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 25, pp. 2395 - 2406
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 3547 - 3547
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4558 - 4565
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 06/2018, Volume 101, Issue 2, pp. 490 - 491
Journal Article
Fundamental & Clinical Pharmacology, ISSN 0767-3981, 12/2019, Volume 33, Issue 6, pp. 679 - 686
Chemotherapy is an essential therapy in the fight against cancer. Polypathology and polymedication are often encountered in elderly patients, making this... 
toxicity | prediction | modeling | docetaxel | Bayesian network | Elderly people | Toxicity | Anthropometry | Cytotoxicity | Radiation therapy | Dosage | Fragility | Side effects | Chemotherapy | Algorithms | Surgery | Predictions | Taxation | Bayesian analysis | Cancer | Geriatrics
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 04/2018, Volume 8, p. 83
Journal Article